A new report shows that about one-third of the world’s dementia and Alzheimer’s cases are preventable by addressing...

The U.S. Food and Drugs Administration approved Thursday the sale of 23andMe’s personal genetic tests for ten diseases,...

Toronto – The 15-month trial drug, leuco-methylthioninium-bis (LMTM) failed to be significant for treating Alzheimer’s disease...

A new research published in the journal Plos Medicine is turning medical science upside down by revealing that people with...